These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 3951327)

  • 1. Pharmacokinetics of imipramine are affected by age and sex in rats.
    Wilson MA; Roy EJ
    Life Sci; 1986 Feb; 38(8):711-8. PubMed ID: 3951327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cerebral pharmacokinetics of imipramine in rats after single and multiple dosages.
    Daniel W; Adamus A; Melzacka M; Szymura J; Vetulani J
    Naunyn Schmiedebergs Arch Pharmacol; 1981 Nov; 317(3):209-13. PubMed ID: 7322212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting imipramine dose in children with depression.
    Sallee F; Stiller R; Perel J; Rancurello M
    Clin Pharmacol Ther; 1986 Jul; 40(1):8-13. PubMed ID: 3720179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma concentration monitoring of hydroxylated metabolites of imipramine and desipramine.
    DeVane CL; Jusko WJ
    Drug Intell Clin Pharm; 1981 Apr; 15(4):263-6. PubMed ID: 7274042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cerebral and blood pharmacokinetics of imipramine and its active metabolites in the pregnant rat.
    DeVane CL; Simpkins JW; Stout SA
    Psychopharmacology (Berl); 1984; 84(2):225-30. PubMed ID: 6438681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of imipramine and its major metabolites in pregnant rats and their fetuses following a single dose.
    DeVane CL; Simpkins JW
    Drug Metab Dispos; 1985; 13(4):438-42. PubMed ID: 2863107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Age alters the observed response of imipramine binding sites to chronic antidepressant treatment in female rats.
    Wilson MA; Roy EJ
    Eur J Pharmacol; 1984 Nov; 106(2):381-91. PubMed ID: 6099275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronopharmacokinetics of imipramine and desipramine in rat forebrain and plasma after single and chronic treatment with imipramine.
    Lemmer B; Holle L
    Chronobiol Int; 1991; 8(3):176-85. PubMed ID: 1794155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatic metabolism of imipramine after prolonged administration of the drug to rats. An in vivo study.
    Melzacka M; Danek L; Adamus A
    Pol J Pharmacol Pharm; 1987; 39(4):379-86. PubMed ID: 3449809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The distribution of imipramine and desipramine in rat brain regions after single and chronic administration of imipramine.
    Szymura-Oleksiak J; Panas M; Chruściel W
    Pol J Pharmacol Pharm; 1984; 36(1):21-6. PubMed ID: 6462958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of imipramine after single and multiple intravenous administration in rats.
    Szymura-Oleksiak J; Panas M; Chruściel W
    Pol J Pharmacol Pharm; 1983; 35(2):151-7. PubMed ID: 6622297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic dosage of imipramine in animal experiment: concentrations of imipramine and desipramine in the rat brain after various modes of dosage.
    Melzacka M; Rurak A; Danek L; Daniel W; Vetulani J
    Pol J Pharmacol Pharm; 1985; 37(4):525-32. PubMed ID: 4080646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sex differences in the uptake and retention of imipramine and desmethylimipramine in the rat lung.
    Ginsburg E; Hirokata Y; Gram TE
    Life Sci; 1982 Mar; 30(9):757-60. PubMed ID: 7070230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Active metabolites of imipramine and desipramine in man.
    Potter WZ; Calil HM; Sutfin TA; Zavadil AP; Jusko WJ; Rapoport J; Goodwin FK
    Clin Pharmacol Ther; 1982 Mar; 31(3):393-401. PubMed ID: 7060321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of steady-state imipramine and desmethylimipramine plasma concentrations from single-dose data.
    Brunswick DJ; Amsterdam JD; Mendels J; Stern SL
    Clin Pharmacol Ther; 1979 May; 25(5 Pt 1):605-10. PubMed ID: 436362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thyroid accumulation and adverse effects of imipramine and desipramine in rats after long-term administration.
    Rousseau A; Marquet P; Lagorce JF; Sauvage MF; Buxeraud J; Lachâtre G; Raby C
    Pharmacology; 1998 Nov; 57(5):242-8. PubMed ID: 9742289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Model for the kinetics of imipramine and its metabolites in adolescents.
    Dell RB; Hein K; Ramakrishnan R; Puig-Antich J; Cooper T
    Ther Drug Monit; 1990 Sep; 12(5):450-9. PubMed ID: 2293407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The analysis and disposition of imipramine and its active metabolites in man.
    Sutfin TA; DeVane CL; Jusko WJ
    Psychopharmacology (Berl); 1984; 82(4):310-7. PubMed ID: 6427820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urinary desipramine hydroxylation index and steady-state plasma concentrations of imipramine and desipramine.
    Spina E; Arena A; Pisani F
    Ther Drug Monit; 1987 Jun; 9(2):129-33. PubMed ID: 3617150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of combined treatment with imipramine and metyrapone in the forced swimming test in rats. Behavioral and pharmacokinetic studies.
    Rogóz Z; Skuza G; Wójcikowski J; Daniel WA
    Pol J Pharmacol; 2003; 55(6):993-9. PubMed ID: 14730094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.